Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vijay Chandolu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Biomedicine & Biotechnology|June 13, 2012
Cell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particularVijay Chandolu, Crispin R Dass
Current Drug Discovery Technologies|February 1, 2013
Treatment of lung cancer using nanoparticle drug delivery systemsVijay Chandolu, Crispin R Dass
The Journal of Pharmacy and Pharmacology|September 12, 2014
Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosisAnna M Friedhuber, Vijay Chandolu, Somkamon Manchun, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Biomedicine & Biotechnology|June 13, 2012
Cell and molecular biology underpinning the effects of PEDF on cancers in general and osteosarcoma in particularVijay Chandolu, Crispin R Dass
Current Drug Discovery Technologies|February 1, 2013
Treatment of lung cancer using nanoparticle drug delivery systemsVijay Chandolu, Crispin R Dass
The Journal of Pharmacy and Pharmacology|September 12, 2014
Nucleotropic doxorubicin nanoparticles decrease cancer cell viability, destroy mitochondria, induce autophagy and enhance tumour necrosisAnna M Friedhuber, Vijay Chandolu, Somkamon Manchun, et al.
Pageof 1